Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | farnesyl diphosphate synthase | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | cdc2-related kinase 3 | 0.2555 | 0.3138 | 0.8612 |
Trypanosoma cruzi | cdc2-related kinase 1 | 0.2555 | 0.3138 | 0.8612 |
Trypanosoma cruzi | sedoheptulose-1,7-bisphosphatase, putative | 0.1096 | 0.1255 | 0.3443 |
Trypanosoma cruzi | fructose-1,6-bisphosphatase, cytosolic, putative | 0.2947 | 0.3644 | 1 |
Loa Loa (eye worm) | CMGC/CDK/CDC2 protein kinase | 0.2555 | 0.3138 | 0.3138 |
Trypanosoma cruzi | cdc2-related kinase 1 | 0.2555 | 0.3138 | 0.8612 |
Loa Loa (eye worm) | CMGC/CDK/CDC2 protein kinase | 0.2555 | 0.3138 | 0.3138 |
Leishmania major | 0.2947 | 0.3644 | 1 | |
Brugia malayi | cell division control protein 2 homolog | 0.2555 | 0.3138 | 0.6671 |
Loa Loa (eye worm) | cyclin domain-containing protein | 0.0734 | 0.0787 | 0.0787 |
Trichomonas vaginalis | CMGC family protein kinase | 0.2555 | 0.3138 | 1 |
Brugia malayi | fructose-1,6-bisphosphatase | 0.2947 | 0.3644 | 0.7746 |
Brugia malayi | Cyclin, N-terminal domain containing protein | 0.0734 | 0.0787 | 0.1673 |
Trypanosoma cruzi | sedoheptulose-1,7-bisphosphatase, putative | 0.1096 | 0.1255 | 0.3443 |
Giardia lamblia | Kinase, CMGC CDK | 0.2555 | 0.3138 | 1 |
Trypanosoma brucei | fructose-1,6-bisphosphatase | 0.2947 | 0.3644 | 1 |
Trypanosoma brucei | sedoheptulose-1,7-bisphosphatase | 0.1096 | 0.1255 | 0.3443 |
Echinococcus multilocularis | cyclin dependent kinase 1 | 0.2555 | 0.3138 | 0.3138 |
Leishmania major | cell division related protein kinase 2,cdc2-related kinase | 0.2555 | 0.3138 | 0.8612 |
Trichomonas vaginalis | CMGC family protein kinase | 0.2555 | 0.3138 | 1 |
Echinococcus multilocularis | cyclin dependent kinase 5 activator 1 | 0.7872 | 1 | 1 |
Toxoplasma gondii | sedoheptulose-1,7-bisphosphatase | 0.1096 | 0.1255 | 0.3443 |
Loa Loa (eye worm) | hypothetical protein | 0.3768 | 0.4704 | 0.4704 |
Leishmania major | cell division protein kinase 2,cdc2-related kinase | 0.2555 | 0.3138 | 0.8612 |
Mycobacterium ulcerans | geranylgeranyl pyrophosphate synthase | 0.0124 | 0 | 0.5 |
Echinococcus granulosus | fructose 16 bisphosphatase 1 | 0.2947 | 0.3644 | 0.3644 |
Loa Loa (eye worm) | hypothetical protein | 0.3768 | 0.4704 | 0.4704 |
Loa Loa (eye worm) | fructose-1,6-bisphosphatase | 0.2947 | 0.3644 | 0.3644 |
Trypanosoma brucei | cdc2-related kinase 3 | 0.2555 | 0.3138 | 0.8612 |
Echinococcus multilocularis | cyclin dependent kinase | 0.2555 | 0.3138 | 0.3138 |
Toxoplasma gondii | fructose-bisphospatase I | 0.1096 | 0.1255 | 0.3443 |
Toxoplasma gondii | cell-cycle-associated protein kinase CDK, putative | 0.2555 | 0.3138 | 0.8612 |
Entamoeba histolytica | cell division protein kinase 2, putative | 0.2555 | 0.3138 | 0.5 |
Echinococcus granulosus | cyclin dependent kinase | 0.2555 | 0.3138 | 0.3138 |
Giardia lamblia | Kinase, CMGC CDK | 0.2555 | 0.3138 | 1 |
Echinococcus multilocularis | cyclin dependent kinase 1 | 0.2555 | 0.3138 | 0.3138 |
Schistosoma mansoni | serine/threonine protein kinase | 0.2555 | 0.3138 | 0.3138 |
Mycobacterium ulcerans | geranylgeranyl pyrophosphate synthase | 0.0124 | 0 | 0.5 |
Echinococcus granulosus | 5'partial|cyclin dependent kinase 1 | 0.2555 | 0.3138 | 0.3138 |
Plasmodium vivax | protein kinase Crk2 | 0.2555 | 0.3138 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.2555 | 0.3138 | 0.3138 |
Trypanosoma cruzi | cdc2-related kinase 3 | 0.2555 | 0.3138 | 0.8612 |
Echinococcus granulosus | cyclin dependent kinase 1 | 0.2555 | 0.3138 | 0.3138 |
Schistosoma mansoni | fructose-16-bisphosphatase-related | 0.2947 | 0.3644 | 0.3644 |
Loa Loa (eye worm) | hypothetical protein | 0.2528 | 0.3103 | 0.3103 |
Plasmodium falciparum | protein kinase 5 | 0.2555 | 0.3138 | 1 |
Toxoplasma gondii | fructose-bisphospatase II | 0.2947 | 0.3644 | 1 |
Brugia malayi | hypothetical protein | 0.3768 | 0.4704 | 1 |
Brugia malayi | Protein kinase domain containing protein | 0.2555 | 0.3138 | 0.6671 |
Mycobacterium tuberculosis | Probable geranylgeranyl pyrophosphate synthetase IdsA2 (ggppsase) (GGPP synthetase) (geranylgeranyl diphosphate synthase) | 0.0124 | 0 | 0.5 |
Trypanosoma brucei | cdc2-related kinase 1 | 0.2555 | 0.3138 | 0.8612 |
Echinococcus granulosus | cyclin dependent kinase 5 | 0.2555 | 0.3138 | 0.3138 |
Trichomonas vaginalis | CMGC family protein kinase | 0.2555 | 0.3138 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.7872 | 1 | 1 |
Echinococcus multilocularis | cyclin dependent kinase 5 | 0.2555 | 0.3138 | 0.3138 |
Loa Loa (eye worm) | CMGC/CDK/CDK5 protein kinase | 0.2555 | 0.3138 | 0.3138 |
Entamoeba histolytica | cell division protein kinase 2, putative | 0.2555 | 0.3138 | 0.5 |
Trypanosoma cruzi | fructose-1,6-bisphosphatase, cytosolic, putative | 0.2947 | 0.3644 | 1 |
Schistosoma mansoni | cyclin-dependent kinase 5 activator | 0.7872 | 1 | 1 |
Echinococcus multilocularis | fructose 1,6 bisphosphatase 1 | 0.2947 | 0.3644 | 0.3644 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 5 | Inhibition of human FPPS | ChEMBL. | 17963374 |
IC50 (binding) | = 9 uM | Inhibition of human FPPS | ChEMBL. | 17963374 |
IC50 (binding) | = 9 uM | Inhibition of human FPPS | ChEMBL. | 17963374 |
IC50 (functional) | = 95.1 uM | Growth inhibition of human NCI-H460 cells after 4 days by MTT assay | ChEMBL. | 17963374 |
IC50 (functional) | = 95.1 uM | Growth inhibition of human NCI-H460 cells after 4 days by MTT assay | ChEMBL. | 17963374 |
IC50 (functional) | = 100 uM | Growth inhibition of human SF268 cells after 4 days by MTT assay | ChEMBL. | 17963374 |
IC50 (functional) | = 100 uM | Growth inhibition of human SF268 cells after 4 days by MTT assay | ChEMBL. | 17963374 |
IC50 (functional) | = 258 uM | Growth inhibition of human MCF7 cells after 4 days by MTT assay | ChEMBL. | 17963374 |
IC50 (functional) | = 258 uM | Growth inhibition of human MCF7 cells after 4 days by MTT assay | ChEMBL. | 17963374 |
Log IC50 (binding) | = 5 | Inhibition of human FPPS | ChEMBL. | 17963374 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.